HomeInsightsEPS

Glaxosmithkline Consumer Healthcare Ltd(merged) EPS

Glaxosmithkline Consumer Healthcare Ltd(merged) EPS

stocks purchased

₹ 2.7 Cr

Volume Transacted

(Apr 15, 2020)

stocks purchased

2.5 K

Stocks Traded

(Apr 15, 2020)

Last Updated on: Dec 23, 2024

From Blinkx's GPT

No data available

Key Highlights

Historical P/B Ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

Company Fundamentals for GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

Market Price of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

1M

1Y

3Y

5Y

Monitoring GlaxoSmithkline Consumer Healthcare Ltd(Merged) share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Apr 202010753.65
13 Apr 202010232.35
09 Apr 202010365.65
08 Apr 202010615.25
07 Apr 202010590.7
03 Apr 20209367.15
01 Apr 20209548.3
31 Mar 20209993.1
30 Mar 20209452.1
27 Mar 20209413.55

SWOT Analysis Of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Market Cap of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical Revenue of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical EBITDA of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical Net Profit of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Dividend Payout Over Time

No data available

GlaxoSmithkline Consumer Healthcare Ltd(Merged) News Hub

News

Board of GlaxoSmithkline Consumer Healthcare takes on record sanction of scheme of merger

The Board of GlaxoSmithkline Consumer Healthcare at its meeting held on 01 April 2020 has ...

Read more

01 Apr 2020 12:47

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

17 Mar 2020 10:43

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

13 Jan 2020 16:32

News

GlaxoSmithkline Consumer Healthcare to announce Quarterly Result

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

15 Oct 2019 10:38

News

GlaxoSmithkline Consumer Healthcare Ltd up for third straight session

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today. The stoc...

Read more

17 Sep 2019 13:05

News

GlaxoSmithkline Consumer Healthcare Ltd gains for third straight session

GlaxoSmithkline Consumer Healthcare Ltd gained for a third straight session today. The sto...

Read more

22 Aug 2019 13:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

What is the EPS of GlaxoSmithkline Consumer Healthcare Ltd(Merged) stock?

The Earnings Per Share (EPS) of GlaxoSmithkline Consumer Healthcare Ltd(Merged) is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is GlaxoSmithkline Consumer Healthcare Ltd(Merged) EPS calculated?

The EPS of GlaxoSmithkline Consumer Healthcare Ltd(Merged) is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does GlaxoSmithkline Consumer Healthcare Ltd(Merged) report its EPS?

GlaxoSmithkline Consumer Healthcare Ltd(Merged) typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence GlaxoSmithkline Consumer Healthcare Ltd(Merged) EPS?

Factors that influence the EPS of GlaxoSmithkline Consumer Healthcare Ltd(Merged) include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can GlaxoSmithkline Consumer Healthcare Ltd(Merged) EPS growth indicate future performance?

Yes, consistent growth in GlaxoSmithkline Consumer Healthcare Ltd(Merged) EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions